Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2022-01-27 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2022-01-27 English
Outcome of Board Meeting
Regulatory Filings
2022-01-27 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short announcement informing stock exchanges about a scheduled Board of Directors meeting to consider and approve unaudited financial results for a specific quarter and nine months period. It also mentions the trading window closure dates. The document does not contain any financial data or detailed results itself, but rather is a notification of an upcoming event and regulatory compliance. The length is only 1357 characters, which is quite short and fits the pattern of an announcement rather than a full report. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general announcement under SEBI regulations.
2022-01-20 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming the processing of dematerialisation requests for the quarter ended 31 December 2021. It is a compliance certificate from the Registrar and Share Transfer Agent to the company and stock exchanges. The document is short (2995 characters) and serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory filing confirming adherence to SEBI regulations regarding securities dematerialisation. Therefore, it fits best under Regulatory Filings (RNS).
2022-01-17 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal notification from the company Wockhardt Limited to stock exchanges (BSE and NSE) about the outcome of a board meeting held on January 6, 2022. The key content is the approval of a rights issue of equity shares to raise up to ₹1,000 crore. The document mentions the board's authorization of the Capital Raising Committee to decide on terms of the issue. It is an announcement of a financing activity, specifically a capital raising event. The document is short (2303 characters) and does not contain detailed financial statements or analysis, so it is not a full financial report. It is not a report publication announcement since it contains substantive information about the board decision. The content fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-01-06 English
Board Meeting — Fund Raising
Capital/Financing Update Classification · 95% confidence The document is a notice informing the stock exchanges about an upcoming board meeting scheduled for January 6, 2022. The purpose of the meeting includes considering and approving various fundraising options. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 29, which pertains to disclosures about board meetings and related decisions. The document does not contain any financial data, results, or detailed report content. It is an announcement about a board meeting and potential capital raising, not the actual report or outcome. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to fundraising activities and board decisions on capital matters.
2022-01-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.